🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, open-label, phase I study of combination therapy with...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2011-09
Trial ID
NCT01434069
Treatments Being Tested
The goal of this clinical research study is to learn if the study drug SOM ...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2011-06
Trial ID
NCT01385956
Treatments Being Tested
The purpose of this study is to allow continued use of pasireotide in patie...
Status
Completed
Location
Ximed Research SC - SOM230B2412
Start Date
2013-06-10
Trial ID
NCT01794793
Treatments Being Tested
To evaluate efficacy, safety, pharmacokinetics and pharmacodynamics of pasi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10-16
Trial ID
NCT01673646
Treatments Being Tested
The goal of this clinical research study is to learn if the study drug, Pas...
Status
Completed
Location
Stanford Cancer Institute
Start Date
2011-02-01
Trial ID
NCT01253161
Treatments Being Tested
Observe the safety/tolerability and effectiveness in terms of response rate...
Status
Withdrawn
Location
Penn State Milton S. Hershey Medical Center
Start Date
2010-12
Trial ID
NCT01234974
Treatments Being Tested
This is a phase II, open-label, 12-month pilot study in 10 patients with si...
Status
Terminated
Location
Neuroendocrine Unit and Pituitary Center, Columbia University
Start Date
2017-07-10
Trial ID
NCT02749227
Treatments Being Tested
The study was designed to investigate the optimal management of hyperglycem...
Status
Completed
Location
Diabetes and Endocrine Associates La Mesa Location
Start Date
2014-05-23
Trial ID
NCT02060383
Treatments Being Tested
This study will evaluate long-term safety and tolerability of pasireotide L...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-05-18
Trial ID
NCT01590199
This study will estimate the treatment effect of everolimus in combination ...
Status
Terminated
Location
Dana Farber Cancer Institute SC-2
Start Date
2011-06
Trial ID
NCT01374451
Treatments Being Tested